Feb 16, 2017 11:28 AM IST | Source:

Hold Glaxosmithkline; target of Rs 5773: Edelweiss

Edelweiss recommended hold rating on Glaxosmithkline with a target price of Rs 5773 in its research report dated February 13, 2017.

Hold Glaxosmithkline; target of Rs 5773: Edelweiss

Edelweiss' research report on Glaxosmithkline

GSK Consumer’s (GSK) Q3FY17 revenue (down 11.7% YoY) came in line, while EBITDA (down 9.5%) and PAT (down 8.3%) slightly surpassed our estimates. Domestic health food drinks’ (HFD) and overall company volumes plummeted 17% YoY.


In our view, this also reflects increased competition from Patanjali Powervita, Sri Sri Ojasvita and substitutes such as Hershey’s syrup. Gross margin fell 93bps YoY as commodity prices (especially milk, sugar) have started inching up. A&P spends remained soft yet again—down 26.1% and 213bps YoY as percentage of sales. Maintain ‘HOLD’.

For all recommendations, click here

The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.
Follow us on
Available On